![Lars Abrahmsén](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Lars Abrahmsén
Teknisk/Vetenskaplig/F&U Direktör på
Akinion Pharmaceuticals AB
Profil
Lars Abrahmsén is currently working as CSO & VP-Preclinical Development at Akinion Pharmaceuticals AB and KDev Oncology AB. He previously worked as Principal at Genentech, Inc., Senior Project Team Leader at Pharmacia & Upjohn, Inc., Chief Scientific Officer at Affibody AB, Senior Project Team Leader at Biovitrum AB, Senior Vice President-Protein Therapeutics at Algeta ASA, CSO & VP-Preclinical Development at Axelar AB, and Principal at Kabi Pharmacia.
He completed his graduate and doctorate degrees from the Royal Institute of Technology.
Aktiva positioner av Lars Abrahmsén
| Företag | Position | Start |
|---|---|---|
Akinion Pharmaceuticals AB
 Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Teknisk/Vetenskaplig/F&U Direktör | - |
KDev Oncology AB
 KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Teknisk/Vetenskaplig/F&U Direktör | - |
Tidigare kända positioner av Lars Abrahmsén
| Företag | Position | Slut |
|---|---|---|
| APREA THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2022-08-02 |
| ALGETA ASA | Företagsledare/Principal | 2013-01-01 |
Affibody AB
 Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Teknisk/Vetenskaplig/F&U Direktör | 2010-01-01 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Företagsledare/Principal | - |
Axelar AB
 Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Teknisk/Vetenskaplig/F&U Direktör | - |
Lars Abrahmséns utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
19
Första gradens relationer
11
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 11 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Pharmacia & Upjohn, Inc.
 Pharmacia & Upjohn, Inc. Pharmaceuticals: MajorHealth Technology Pharmaceutical Preparations | Health Technology |
Affibody AB
Affibody AB BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops radioligand therapies for cancer treatment | Health Technology |
Biovitrum AB
 Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Develops pharmaceuticals and conducts medical research services | Commercial Services |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Axelar AB
Axelar AB BiotechnologyHealth Technology Provides oral anti-cancer therapies | Health Technology |
Kabi Pharmacia | |
Akinion Pharmaceuticals AB
Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops pharmaceutical for the treatment of acute myeloid leukemia | Health Technology |
KDev Oncology AB
KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services Offers research and development services in the field of oncology | Commercial Services |
Aprea Therapeutics, Inc.
 Aprea Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops novel anticancer compounds | Health Technology |
